Back to search
FDAFDA · Food and drugs·Recall number D-368-2014

10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield IL 60015 USA. NDC: 0338-0644-06.

Published December 25, 2013 · Recall initiated: November 12, 2013

Summary

FDA records drug Class II recall D-368-2014, published December 25, 2013 and initiated November 12, 2013. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 14,622 bags; Lot: Lot: P302646, Exp 5/31/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

What to do

Voluntary: Firm initiated · Letter

Get an email if TRAVASOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRAVASOL
Manufacturer
Baxter Healthcare Corp.
Distributor
Nationwide
Lot
Lot: P302646, Exp 5/31/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield IL 60015 USA. NDC: 0338-0644-06. recalled?

Yes. FDA published recall D-368-2014 on December 25, 2013. Reported hazard: Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRAVASOL.